We are live on ! Find out more
IHAM

Integral Health Asset Management Portfolio holdings

AUM $2.09B
1-Year Est. Return 112.84%
This Fund
S&P 500
This Quarter Est. Return
+5.53%
1 Year Est. Return
+112.84%
3 Year Est. Return
+485.32%
5 Year Est. Return
+783.01%
10 Year Est. Return
–
AUM
$2.09B
AUM Growth
+$76.9M
Cap. Flow
+$113M
Cap. Flow %
5.39%
Top 10 Hldgs %
44.54%
Holding
114
New
28
Increased
33
Reduced
17
Closed
24

Top Buys

Rank Stock Value
1
INSM icon
Insmed
INSM
+$38.4M
2
RVMD icon
Revolution Medicines
RVMD
+$30.3M
3
ROIV icon
Roivant Sciences
ROIV
+$29.5M
4
BSX icon
Boston Scientific
BSX
+$26M
5
MRK icon
Merck
MRK
+$20.2M

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$64.8M
2
ISRG icon
Intuitive Surgical
ISRG
+$37.9M
3
TEVA icon
Teva Pharmaceuticals
TEVA
+$31.2M
4
PEN icon
Penumbra
PEN
+$31.1M
5
TFX icon
Teleflex
TFX
+$30.5M

Sector Composition

Rank Sector Weight
1 Healthcare 90.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DXCM icon
51
DexCom
DXCM
$33.1B
$11M 0.53%
175,000
-325,000
-65% -$22.6M
SLNO
52
DELISTED
Soleno Therapeutics
SLNO
$10.9M 0.52%
325,000
– –
IRON icon
53
Disc Medicine
IRON
$3.01B
$10.9M 0.52%
+170,000
New +$11.8M
NRIX icon
54
Nurix Therapeutics
NRIX
$2.69B
$10.8M 0.52%
700,000
+400,000
+133% +$6.63M
CVS icon
55
CVS Health
CVS
$122B
$10.8M 0.52%
150,000
-350,000
-70% -$27M
COO icon
56
Cooper Companies
COO
$14.9B
$10.7M 0.51%
150,000
-175,000
-54% -$13.8M
TMO icon
57
Thermo Fisher Scientific
TMO
$222B
$9.83M 0.47%
+20,000
New +$10.9M
LIVN icon
58
LivaNova
LIVN
$4.21B
$9.53M 0.46%
+150,000
New +$9.67M
LNTH icon
59
Lantheus
LNTH
$6.59B
$9.48M 0.45%
125,000
+25,000
+25% +$1.79M
TNGX icon
60
Tango Therapeutics
TNGX
$4.51B
$9.41M 0.45%
450,000
+250,000
+125% +$3.48M
IONS icon
61
Ionis Pharmaceuticals
IONS
$9.46B
$9.39M 0.45%
+125,000
New +$9.87M
SANA icon
62
Sana Biotechnology
SANA
$1B
$9.22M 0.44%
3,200,000
+200,000
+7% +$788K
CELC icon
63
Celcuity
CELC
$4.43B
$9.13M 0.44%
80,000
– –
TARA icon
64
Protara Therapeutics
TARA
$231M
$9.12M 0.44%
1,750,000
-500,000
-22% -$2.96M
NVST icon
65
Envista
NVST
$4.53B
$8.88M 0.42%
350,000
-150,000
-30% -$3.89M
BHVN icon
66
Biohaven
BHVN
$2.19B
$8.46M 0.4%
1,000,000
-500,000
-33% -$5.47M
SNDX icon
67
Syndax Pharmaceuticals
SNDX
$1.82B
$8.18M 0.39%
350,000
+150,000
+75% +$3.26M
VKTX icon
68
Viking Therapeutics
VKTX
$4.02B
$8.13M 0.39%
250,000
+150,000
+150% +$4.82M
DFTX
69
Definium Therapeutics
DFTX
$5.99B
$7.56M 0.36%
400,000
+50,000
+14% +$848K
BEAM icon
70
Beam Therapeutics
BEAM
$2.82B
$7.15M 0.34%
300,000
-250,000
-45% -$6.94M
RZLT icon
71
Rezolute
RZLT
$451M
$6.1M 0.29%
2,000,000
– –
CAPR icon
72
Capricor Therapeutics
CAPR
$223M
$6.08M 0.29%
+200,000
New +$5.33M
IQV icon
73
IQVIA
IQV
$39.8B
$5.97M 0.29%
+35,000
New +$6.83M
AXSM icon
74
Axsome Therapeutics
AXSM
$11.4B
$5.92M 0.28%
+35,000
New +$6.05M
PTGX icon
75
Protagonist Therapeutics
PTGX
$9.71B
$5.27M 0.25%
+50,000
New +$4.43M
1 2
3
4 5

Similar funds

CL
CSS LLC Chicago, Illinois $2.09B AUM 58.96% 1-Year Est. Return
ACM
Analog Century Management New York $2.09B AUM 186.85% 1-Year Est. Return
ACG
Aventail Capital Group New York $2.09B AUM 43.81% 1-Year Est. Return
NSUP
NLB Skladi upravljanje premozenja Ljubljana $2.09B AUM
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
ACP
Avantyr Capital Partners New York $2.08B AUM
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return
AG
Avala Global New York $2.08B AUM 87.66% 1-Year Est. Return

Integral Health Asset Management's Q1 2026 Portfolio in Review

As of Q1 2026, Integral Health Asset Management held 114 positions worth $2.09B, up 3.8% from $2.01B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Integral Health Asset Management deployed $113M of net new capital in Q1 2026, opening 28 new positions and adding to 33 existing holdings. Its largest new stake was Alumis Inc: 800,000 shares worth $17.6M.

By sector, the portfolio is most concentrated in Healthcare at 90% of assets, down from 98% a quarter earlier.

On the sell side, the largest reduction was Intuitive Surgical, an estimated $37.9M trimmed.

  • Integral Health Asset Management's largest Q1 2026 buy was Alumis Inc: 800,000 shares worth $17.6M.
  • Integral Health Asset Management added most to Insmed in Q1 2026, an estimated $38.4M increase.
  • Integral Health Asset Management's biggest Q1 2026 reduction was Intuitive Surgical, cutting an estimated $37.9M.
  • Integral Health Asset Management fully exited Medtronic in Q1 2026, selling an estimated $64.8M.
  • Integral Health Asset Management's ten largest holdings make up 45% of its $2.09B portfolio in Q1 2026.
  • Integral Health Asset Management opened 28 new positions and closed 24 in Q1 2026.
  • Integral Health Asset Management's portfolio value rose 3.8% quarter-over-quarter to $2.09B.

Based on Integral Health Asset Management's 13F filing for Q1 2026, filed 15 May 2026.